MOMO'S BREAKOUT BOARD

[stockhits]

VSTA-Read the bold print, it is what sets Vistagen from the rest.
VistaGen Therapeutics has the ability to work directly with human cells offers a way for pharmaceutical companies to save money while risking less of it. VistaGen has developed a way to use advanced stem cell technology to generate human cell based bioassay systems that allow new drug candidates to be effectively tested for possible toxicity without having to expend the volumes of money and effort required to take a drug all the way to human clinical trial. It’s a highly accurate and economical way to identify problems early on, in addition to making it feasible to cost-effectively develop non-toxic drug variants, so that promising drugs aren’t shelved unnecessarily.